<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Reperfusion after <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e> causes <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> formation and microcirculatory disturbances, which are dependent on the platelet <z:chebi fb="2" ids="17089">glycoprotein</z:chebi> Ib-<z:e sem="disease" ids="C0042974" disease_type="Disease or Syndrome" abbrv="">von Willebrand</z:e> factor (VWF) axis </plain></SENT>
<SENT sid="1" pm="."><plain>Because ADAMTS13 cleaves VWF and limits platelet-dependent <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> growth, ADAMTS13 may ameliorate ischemic brain damage in <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>We investigated the effects of ADAMTS13 on <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-reperfusion injury using a 30-minute middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> model in Adamts13(-/-) and <z:mp ids='MP_0002169'>wild-type</z:mp> mice </plain></SENT>
<SENT sid="3" pm="."><plain>After reperfusion for 0.5 hours, the regional cerebral blood flow in the ischemic cortex was decreased markedly in Adamts13(-/-) mice compared with <z:mp ids='MP_0002169'>wild-type</z:mp> mice (P &lt; .05), which also resulted in a larger <z:mpath ids='MPATH_124'>infarct</z:mpath> volume after 24 hours for Adamts13(-/-) compared with <z:mp ids='MP_0002169'>wild-type</z:mp> mice (P &lt; .01) </plain></SENT>
<SENT sid="4" pm="."><plain>Thus, Adamts13 gene deletion aggravated ischemic brain damage, suggesting that ADAMTS13 may protect the brain from <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> by regulating VWF-platelet interactions after reperfusion </plain></SENT>
<SENT sid="5" pm="."><plain>These results indicate that ADAMTS13 may be a useful therapeutic agent for <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
</text></document>